D-0897-2017 Class III Terminated

Recalled by Hetero USA Inc — Piscataway, NJ

FDA drug recall D-0897-2017 was initiated by Hetero USA Inc on Apr 27, 2017 and is designated Class III. Reason for recall: Presence of Foreign Substance: human hair melded into tablet. The recall status is terminated (terminated Dec 13, 2017). Affected quantity: 13,692 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 14, 2017
Initiation Date
Apr 27, 2017
Termination Date
Dec 13, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
13,692 bottles

Product description

Acyclovir Tablets, USP, 800 mg, 100-count bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, by Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India, NDC 31722-778-01

Reason for recall

Presence of Foreign Substance: human hair melded into tablet.

Distribution pattern

Nationwide

Code information

Lot # ACY16075 Exp. 09/2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0897-2017
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0897-2017. Report a data issue: hello@regdatalab.com.